Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Regenerative Medicine for Hair Health: From Principles to Practice (Part II).

Wyles SP., Proffer SL., Pastore L., Alam M., Avram M., Farah R.

Narrative Review on Scar, Hair Loss, Hair Regeneration, Autoimmune Research, published in J Am Acad Dermatol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Am Acad Dermatol (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41621669
DOI
10.1016/j.jaad.2026.01.060

Abstract (original English)

Regenerative technologies are increasingly being explored to support hair growth and follicular restoration, but most remain experimental and grounded in early-stage biological insights. Developmental biology has revealed key signaling pathways, such as WNT, BMP, and SHH, that regulate hair follicle formation and cycling within the bulge and dermal papilla. Building on these principles, a range of regenerative modalities are being studied, including mesenchymal stem cells (MSCs), platelet-rich plasma (PRP) derivatives, and extracellular vesicles (exosomes) derived from bone marrow, adipose tissue, umbilical cord, and platelets, among other sources. These therapies show potential across scarring, non-scarring, and autoimmune alopecia, yet remain limited by variability in protocols, lack of standardized characterization, and the need for long-term safety and regulatory guidance.. This CME article is intended as an educational overview rather than a therapeutic endorsement. Its primary goal is to define terminology, summarize scientific principles, and highlight current research directions to support clinician and trainee understanding. As regenerative therapies continue to evolve, closing the educational gap will help the dermatology community critically evaluate emerging data and responsibly integrate future advances with appropriate scientific, ethical, and regulatory rigor.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research